The biggest barrier to moving toward a value-based at-risk model has been executives’ fear of potential loss if they move away from fee-for-service. But the coronavirus has taught us that the potential for loss in fee-for-service is bottomless.
PrEP, the life-saving HIV prevention drug, was due to be avaiblle on the NHS in April, become available and uncapped on the NHS, the Health Secretary Matt Hancock announced today.
PrEP, the life-saving HIV prevention drug, was due to be avaiblle on the NHS in April, become available and uncapped on the NHS, the Health Secretary Matt Hancock announced today.
Biotech company Moderna, which is among the leaders in the race to develop a coronavirus vaccine, on Thursday named a sector veteran its new finance chief, as it gears up to launch commercial operations and potentially oversee explosive growth if it su…